⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL862556 | 1.00 | — | — | |
| SCHEMBL13335936 | 0.75 | — | — | |
| SCHEMBL18854459 | 0.72 | — | — | |
| SCHEMBL11605748 | 0.70 | LMNA (0.34) | — | |
| SCHEMBL10667700 | 0.70 | LMNA (0.34) | — | |
| SCHEMBL23488356 | 0.69 | — | — | |
| SCHEMBL14999446 | 0.69 | — | — | |
| SCHEMBL18843051 | 0.69 | — | — | |
| SCHEMBL14724318 | 0.69 | — | — | |
| SCHEMBL28269972 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11189808-B2 | Platinum complexes and devices | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2021-11-30 | — | — | US | disclosed |
| US-20200152891-A1 | PLATINUM COMPLEXES AND DEVICES | UNIV ARIZONA STATE (US) | 2020-05-14 | — | — | US | disclosed |
| EP-3154997-B1 | AURISTATIN DERIVATIVES AND CONJUGATES THEREOF | NOVARTIS AG (CH) | 2020-02-19 | — | — | EP | disclosed |
| WO-2018069863-A1 | 1,3 DI-SUBSTITUTED CYCLOBUTANE OR AZETIDINE DERIVATIVES AS HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE INHIBITORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2018-04-19 | — | — | WO | disclosed |
| US-9809621-B2 | Stable peptide-based PACE4 inhibitors | SOCPRA SCIENCES SANTÉ ET HUMAINES S.E.C. (CA) | 2017-11-07 | — | — | US | disclosed |
| US-20170290927-A1 | CHARGE-BALANCED IMAGING AGENTS | BETH ISRAEL DEACONESS MEDICAL CT INC (US) | 2017-10-12 | — | — | US | disclosed |
| US-20170290928-A1 | USE OF CHARGE-BALANCED IMAGING AGENTS FOR DETERMINING RENAL FUNCTION | BETH ISRAEL DEACONESS MEDICAL CT INC (US) | 2017-10-12 | — | — | US | disclosed |
| US-9687567-B2 | Charged-balanced imaging agents | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2017-06-27 | — | — | US | disclosed |
| EP-2136354-B1 | Display device, liquid crystal display device and electronic device including the same | SEMICONDUCTOR ENERGY LAB (JP) | 2017-03-22 | — | — | EP | disclosed |
| WO-2015189791-A1 | AURISTATIN DERIVATIVES AND CONJUGATES THEREOF | NOVARTIS AG (CH) | 2015-12-17 | — | — | WO | disclosed |
| US-20150209451-A1 | CHARGED-BALANCED IMAGING AGENTS | BETH ISRAEL HOSPITAL (US) | 2015-07-30 | — | — | US | disclosed |
| US-20150141324-A1 | STABLE PEPTIDE-BASED FURIN INHIBITORS | SOCPRA Sciences Sante et Humaines S.E.C. (CA) | 2015-05-21 | — | — | US | disclosed |
| US-9023611-B2 | Charged-balanced imaging agents | BETH ISRAEL DEACONESS MEDICAL CENTER (US) | 2015-05-05 | — | — | US | disclosed |
| US-20140206622-A1 | STABLE PEPTIDE-BASED PACE4 INHIBITORS | SOCPRA Sciences Sante et Humaines S.E.C. (CA) | 2014-07-24 | — | — | US | disclosed |
| US-20140200215-A1 | LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS | INTERMUNE, INC. | 2014-07-17 | — | — | US | disclosed |
| US-20120028291-A1 | CHARGED-BALANCED IMAGING AGENTS | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2012-02-02 | — | — | US | disclosed |